Search details
1.
Increase in chemokine CXCL1 by ERß ligand treatment is a key mediator in promoting axon myelination.
Proc Natl Acad Sci U S A
; 115(24): 6291-6296, 2018 06 12.
Article
in English
| MEDLINE | ID: mdl-29844175
2.
Multiple functional therapeutic effects of the estrogen receptor ß agonist indazole-Cl in a mouse model of multiple sclerosis.
Proc Natl Acad Sci U S A
; 111(50): 18061-6, 2014 Dec 16.
Article
in English
| MEDLINE | ID: mdl-25453074
3.
Optimization of the preparation of fluorine-18-labeled steroid receptor ligands 16alpha-[18F]fluoroestradiol (FES), [18F]fluoro furanyl norprogesterone (FFNP), and 16beta-[18F]fluoro-5alpha-dihydrotestosterone (FDHT) as radiopharmaceuticals.
J Labelled Comp Radiopharm
; 57(5): 371-7, 2014 May 15.
Article
in English
| MEDLINE | ID: mdl-24861984
4.
Analogues of ERß ligand chloroindazole exert immunomodulatory and remyelinating effects in a mouse model of multiple sclerosis.
Sci Rep
; 9(1): 503, 2019 01 24.
Article
in English
| MEDLINE | ID: mdl-30679747
5.
Bioprocess development of antibody-drug conjugate production for cancer treatment.
PLoS One
; 13(10): e0206246, 2018.
Article
in English
| MEDLINE | ID: mdl-30352095
6.
Preparation of o-Fluorophenols from Nonaromatic Precursors: Mechanistic Considerations for Adaptation to Fluorine-18 Radiolabeling.
Org Lett
; 17(22): 5540-3, 2015 Nov 20.
Article
in English
| MEDLINE | ID: mdl-26536250
7.
Selective Delivery of an Anticancer Drug with Aptamer-Functionalized Liposomes to Breast Cancer Cells in Vitro and in Vivo.
J Mater Chem B
; 1(39): 5288-5297, 2013 Oct 21.
Article
in English
| MEDLINE | ID: mdl-24159374
Results
1 -
7
de 7
1
Next >
>>